Congress Proposes Plan to Lower Drug Costs by Allowing Imports from Canada and Europe
Stalled
No legislative action in over 90 days.
Small business owners who provide health insurance to their employees often struggle with rising prescription drug costs that drive up premiums. If drug importation creates meaningful price competition, it could help lower the cost of employer-sponsored health plans. Small businesses that self-insure would see the most direct benefit from cheaper drug purchasing options.
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
Rep. Janice Schakowsky introduced the Affordable and Safe Prescription Drug Importation Act, which would allow Americans to buy drugs from certified pharmacies in Canada, the UK, and the EU. The bill covers insulin and injectable drugs but excludes controlled substances.
The article discusses Rep. Schakowsky's importation bill in the context of a new Executive Order and other legislative efforts like Rep. Ro Khanna's 'Global Fairness in Drug Pricing Act,' highlighting the bipartisan interest in lowering costs through international competition.
A year-end summary highlighting the introduction of the Affordable and Safe Prescription Drug Importation Act in May 2025 as a key development in the effort to control rising pharmacy costs and pressure domestic drug pricing.
Document Type
Congressional Bill
Official Title
Affordable and Safe Prescription Drug Importation Act of 2025
Analysis generated by AI. Always verify with official sources.